(Q51056946)

27 March 2018

title

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. (English)

1 reference

27 March 2018

mild cognitive impairment

1 reference

1 reference

2

1 reference

27 March 2018

Marcia Radanovic

4

1 reference

27 March 2018

Monica S Yassuda

Monica S Yassuda

5

0 references

Wagner Farid Gattaz

7

Wagner F Gattaz

1 reference

27 March 2018

Leda L Talib

3

Leda L Talib

1 reference

27 March 2018

Orestes V Forlenza

1

Orestes V Forlenza

1 reference

27 March 2018

author name string

Elida B Ojopi

6

1 reference

27 March 2018

publication date

16 April 2010

1 reference

27 March 2018

Brazilian Journal of Psychiatry

published in

1 reference

27 March 2018

volume

32

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

216-222

1 reference

27 March 2018

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Prevalence of cognitive and functional impairment in a community sample from São Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Incidence of mild cognitive impairment and Alzheimer disease in Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Mini-mental State Examination performance in mild cognitive impairment subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Mild cognitive impairment: cognitive screening or neuropsychological assessment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Conversion to dementia from mild cognitive disorder: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Voxel-based morphometry in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Brain imaging evidence of preclinical Alzheimer's disease in normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Guaranteed stimulus-processing in the evaluation of memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462010005000002

10.1590/S1516-44462010005000002

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018